The study was small — just 48 adults — and lasted just over two months, so it’s not the final word. But the results add to evidence that GLP-1 drugs like Ozempic might help with cravings for things ...
Criminals are targeting pharmacies and stealing weight-loss medication in a country with body image insecurities and where ...
Excess body weight—including overweight and obesity—is a significant risk factor for cancer. Research from the American Cancer Society estimates that it contributes to approximately 5 percent of ...
People with type 2 diabetes who take GLP-1 and SGLT-2 medications have a lower risk of having COPD symptom flare-ups than ...
Nita Ambani recently revealed about the obesity struggles that Anant Ambani deals. The conversation they had before his ...
President Trump established by way of executive order a Make America Healthy Again Commission. However, much of what’s ...
Right now, our state’s most vulnerable populations that rely on Medicare and Medicaid are unable to access anti-obesity ...
West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...
People living in rural areas are at greater risk for obesity than the general population, and they often have limited access ...
A game-changer for obesity and heart failure? Dr Pandey reveals breakthrough GLP-1 trial results that show reduced cardiovascular risk and better outcomes for HFpEF patients. Don’t miss this!
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback